INTRODUCTION
The amyloid precursor protein (APP) is sequentially cleaved to generate amyloid-beta (Ab) peptides-pathologic hallmarks of Alzheimer's disease (AD)-via the ''amyloidogenic pathway.'' The rate-limiting step in this pathway is the cleavage of APP by the aspartyl protease b-site APP-cleaving enzyme-1 (BACE-1), making the physical proximity of APP (substrate) and BACE-1 (enzyme) an obligatory step initiating this pathway (Thinakaran and Koo, 2008) . As continued proximity of APP/BACE-1 might lead to relentless pathology, it seems reasonable that cellular pathways would spatially segregate this enzyme/substrate pair in physiologic states. However, to date, the precise trafficking pathways of APP and BACE-1 in neurons-including mechanisms that dictate divergence/convergence of these two proteins-are unclear.
While previous studies have examined the subcellular localization of the transmembrane proteins APP and BACE-1, there are two major caveats. First, most studies have been performed in a variety of nonneuronal cells or neuronal cell lines that lack the unique morphology and compartmentalization of neurons. Accordingly, reported locales of these proteins range from the endoplasmic-reticulum (ER)/Golgi, cell membranes/lipid rafts, to endosomal-lysosomal organelles (Greenfield et al., 1999; Ehehalt et al., 2003; reviewed in Brunholz et al., 2012 and Annaert, 2012) . Furthermore, most have examined the trafficking of mutant (and not wild-type) APP. Second, the vast majority of studies have been performed in fixed cells and have not fully accounted for the dynamic nature of these peptides that are continuously trafficking in neurons (see below). Importantly, vesicle-trafficking pathways in highly polarized cells like neurons are unique compared to other cell types. For instance, neurons have an extensive and sophisticated network of recycling endosomes that are scattered throughout the processes, unlike nonneuronal cells, in which this system is relatively small and typically clustered around the nucleus (Yap and Winckler, 2012) . Although some studies have examined APP/BACE-1 trafficking in polarized epithelial cells, extrapolation of these data to neurons has been complicated (reviewed in Haass et al., 2012) .
Toward this, we explored the dynamic localization of APP and BACE-1 in cultured hippocampal neurons, expressing low levels of fluorescent-tagged proteins and examining their trafficking and organelle composition in neuronal soma and processes with high resolution. We also designed imaging paradigms that revealed basic mechanisms leading to APP/BACE-1 convergence and initiation of the amyloidogenic pathway. Finally, we also examined the spatial localization of these proteins in mouse and human brains in vivo. Our data reveal surprising aspects of neuronal APP/BACE-1 trafficking that are quite different from that seen in other simpler cell types and also help define a mechanistic pathway for activity-dependent amyloidogenesis.
RESULTS

Segregation of APP and BACE-1 into Distinct Neuronal Microdomains
We first visualized the trafficking of APP and BACE-1 in neurons. Toward this, we transfected cultured hippocampal neurons with low levels of APP/BACE-1 tagged to green/red fluorescent proteins (GFP/mCherry, see Figures S1A-S1D available online) and simultaneously visualized their trafficking in somatodendritic compartments after 4-6 hr-a time when these fusion proteins are just starting to be expressed (schematic in Figure 1A ). We focused on somatodendritic compartments, as the spatial separation/convergence of APP/BACE-1 fluorescence could be confidently evaluated in these wider profiles (see below); recent reports also implicate dendrites in APP processing (Wei et al., 2010; Wu et al., 2011) . Tubulovesicular structures carrying APP and BACE-1 moved bidirectionally within the dendritic shaft and the movement was microtubule dependent, resembling the movement of motor-driven vesicular cargoes (Figures S1E and S1F; Movie S1; Table S1 ; also see Tang et al., 2012) . As shown in the kymographs ( Figure 1B) , localization of both stationary and mobile APP/BACE-1 particles were largely nonoverlapping ( Figure 1B , bar graph). Subtle differences were also seen in the transport kinetics of APP and BACE-1 vesicles ( Figure 1C ), further suggesting that these two cargoes were largely conveyed in distinct organelles.
Next, to examine the biogenesis of APP/BACE-1 cargoes, we focused on the distribution of these proteins within the neuronal soma. As both APP and BACE-1 are transmembrane proteins, they would be expected to traffic via the ER/Golgi (biosynthetic) pathway. In accordance with this, we found significant colocalization of APP and BACE-1 in the perinuclear region ( Figure 1D )-a distribution reminiscent of the ER-Golgi network in these neurons (Dresbach et al., 2006 ; also see overlap with Golgi marker galactosyl-transferase [GalT] below). However, we also saw BACE-1 particles ( Figure 1D , arrowheads) that did not colocalize with APP, suggesting that BACE-1 may be sorted into a distinct compartment after trafficking via the ER/Golgi pathway. If the latter was true, conditions inhibiting the emergence of Golgi-derived vesicles would be expected to ''trap'' APP/BACE-1 within the Golgi network. To test this idea, we incubated cultured neurons at 20 C for 2 hr-conditions expected to block the exit of Golgi-derived proteins (Dresbach et al., 2006) . Indeed, we found that the perinuclear colocalization of APP/BACE-1 was significantly increased under these conditions ( Figure 1D , inset), further suggesting that the subset of somatic BACE-1 that failed to colocalize with APP at 37 C was a consequence of post-Golgi processing. Increased colocalization of BACE-1 with GalT at 20 C also supports this overall model ( Figure 1D ). Moreover, APP/BACE-1 colocalization decreased over 6-36 hr posttransfection ( Figure 1D , bottom), further suggesting a differential sorting after biogenesis. The spatial segregation of APP and BACE-1 was also evident in sucrose density gradients of P100 (''vesicle pellet''; DeBoer et al., 2008 ; see fractionation strategy in Figure S1G ) mouse brain fractions in vivo, in which endogenous holo-APP/BACE-1 were largely localized to distinct fractions ( Figure 1E ).
BACE-1 Is Largely Conveyed in Neuronal Recycling Endosomes
Next, we sought to determine the specific organelles carrying BACE-1 and APP in neurons. Accordingly, we cotransfected fluorescent-tagged BACE-1 (or APP) with various labeled organelle markers known to highlight specific biosynthetic or endosomal organelles (Yap and Winckler, 2012) and simultaneously visualized the trafficking of BACE-1/organelle markers in dendrites by live imaging. While only 10%-30% of the mobile BACE-1 vesicles colocalized with Golgi markers (see below), surprisingly, the vast majority of BACE-1 was conveyed in vesicles that are known markers of neuronal recycling endosomes (Figures 2A-2C ). Specifically, we simultaneously visualized transport of BACE-1:GFP and TfR:mCherry-previously used as a marker for neuronal recycling endosomes (Park et al., 2006; Wang et al., 2008) . The TfR fusion construct faithfully represents a functional recycling pool, as shown in Figure S2 . Indeed, the vast majority of the trafficking BACE-1 vesicles colocalized with TfR ( Figures  2A-2C ) and also syntaxin-13 ( Figure 2B , middle)-known markers of dendritic recycling endosomes (Park et al., 2006; Prekeris et al., 1999; Silverman et al., 2001; Wang et al., 2008; Yap and Winckler, 2012) . In contrast, few mobile BACE-1 vesicles colocalized with Rab5, a marker for early endosomes ( Figure 2B , bottom). However, unlike mobile vesicles, stationary BACE-1 cargoes colocalized with all tested markers (TfR, syntaxin 13, and Rab5; Figure 2B ). The significance of this is unclear, but such stationary particles are commonly seen when imaging vesicle transport in axons (for example, see Tang et al., 2012) and may represent sites where potential intermingling of biosynthetic and recycling organelles occur.
Next, we asked whether APP colocalized with known markers of the neuronal biosynthetic pathway. Toward this, we cotransfected neurons with APP:mCherry and the signal sequence of neuropeptide-Y (NPYss) fused to GFP-the latter expected to label the interior of Golgi-derived vesicles (El Meskini et al., 2001; Kaech et al., 2012) . Indeed, the vast majority of APP vesicles colocalized with NPYss ( Figure 2D , middle), while there was only 20% colocalization of moving BACE-1 particles with NPYss ( Figure 2D, right) . Notably, <30% of mobile APP vesicles colocalized with TfR (27.92% ± 7.0%/8.33% ± 5.45%, mean ± SEM; APP:GFP anterograde/retrograde particles respectively colocalizing with TfR:mCherry). Finally, P100 density gradients from mouse brains showed that fractions containing endogenous BACE-1 overlapped with a subset of TfR-positive vesicles, though colocalization with other markers were variable ( Figure 2E and Figure S3 ). A schematic view summarizing the above data is presented in Figure 2F .
Activity-Induced Convergence of APP and BACE-1 Occurs Largely in Recycling Compartments
The above experiments suggest that the majority of APP and BACE-1 vesicles are spatially segregated and that APP/BACE-1 colocalization is a low-frequency event under basal conditions. As physical proximity of APP and BACE-1 is an obvious requirement for initiating APP cleavage, we reasoned that conditions triggering Ab generation (i.e., BACE-1 cleavage) should also increase APP/BACE-1 colocalization. Substantial evidence indicates that enhanced neuronal activity leads to an increase in (C) Velocity histograms of mobile APP and BACE-1 vesicles were best fitted by two ''peaks'' (arrowheads; also see Tang et al., 2012) , with subtle differences in anterograde transport kinetics. The distribution of first and second anterograde peaks for APP and BACE was significantly different (APP: 0.33/0.67; BACE: 0.5/ 0.5; first and second peak, respectively; p = .0216), while distribution of first and second retrograde peaks was not (APP: 0.29/0.71; BACE: 0.45/0.55, first and second peak, respectively; p = 0.2549). For both (B) and (C) nearly 100 APP particles and 150 BACE-1 particles in 15-20 neurons were analyzed from two separate culture sets. (D) Neurons were transfected with BACE-1:mCherry and APP:GFP as above, and BACE-1/APP distribution in the soma was analyzed after 4-6 hr. Note that although a large fraction of the BACE-1 colocalizes with APP in a perinuclear ER/Golgi pattern, vesicles containing BACE-1 (but not APP) are also seen (arrowheads). Incubation of neurons at 20 C for 2 hr (expected to block exit of vesicles from the Golgi) greatly increases BACE-1/APP colocalization. Similar results were obtained with BACE-1 and GalT, a Golgi marker. Over time, the extent of APP/BACE-1 colocalization was also diminished, further suggesting differential redistribution of these two proteins after biogenesis. n z 15 neurons analyzed for each temperature/time point, from at least two separate cultures. *p < 0.05; **p < 0.01; ***p < 0.001; two-tailed, unpaired t test.
(E) Sucrose density gradients from ''vesicle-pellet'' fractions of mouse brains (see text) show that endogenous APP and BACE-1 is also largely segregated in vivo. Figure S2 ). The vast majority of Alexa 488 Tf-labeled vesicles were colocalized/cotransported (arrowheads) with BACE-1:mCherry in dendrites. For quantification, nearly 150 BACE-1 and 100 Alexa 488 Tf particles in ten neurons were analyzed from two culture sets.
(D) A large fraction of APP (but not BACE-1) is cotransported with NPYss:mGFP-a marker expected to label the interior of Golgi-derived vesicles (Kaech et al., 2012) . Nearly 120 APP, 150 BACE-1, and 150 NPYss:mGFP particles were analyzed in 15 neurons from two separate culture sets.
(E) Sucrose density gradients from ''vesicle-pellet'' fractions of mouse brains (see text) show an overlap of endogenous BACE-1, a subset of TfR-containing vesicles, but little overlap with the Golgi marker GM-130. (F) Summary schematic. After synthesis in the ER/Golgi, BACE-1 is routed into recycling endosomes, whereas APP remains in Golgi-derived vesicles, leading to a spatial segregation of these two cargoes under physiologic conditions. APP cleavage and amyloidogenesis (Bero et al., 2011; Cirrito et al., 2005 Cirrito et al., , 2008 Kamenetz et al., 2003 , reviewed in Haass et al., 2012 also see Figures 4D and 4E below) . Accordingly, we first asked whether induction of neuronal activity in our model system would also increase APP/BACE-1 colocalization.
To test this idea, we transfected tagged APP and BACE-1 in cultured neurons (as above) and stimulated the neurons using established paradigms (see schematic in Figure 3A ). Indeed, stimulation of neurons with glycine (Lu et al., 2001; Park et al., 2006) resulted in a significant increase in APP/BACE-1 convergence (Figures 3B and 3C) . Preincubation of neurons with inhibitors of NMDA receptors prevented this colocalization ( Figure 3C ), indicating that these changes are a consequence of glycine and NMDA receptor-mediated pathway. Similar results were obtained when neurons were stimulated with K + (data not shown).
As an alternative approach, stimulation of neurons using the GABA A antagonist Picrotoxin (PTX) -known to increase neuronal activity in hippocampal cultures, presumably due to suppression of inhibitory inputs (Neuhoff et al., 1999; Bateup et al., 2011) -also led to an increase in APP/BACE-1 convergence ( Figure 3D ). Note that increases in glycine-induced APP/BACE-1 convergence can be blocked by the NMDA receptor blockers D-AP5 and memantine. n z 15 neurons analyzed for each condition, from at least three separate culture sets. *p < 0.05; **p < 0.01; ***p < 0.001 compared to control by one-way ANOVA followed by Dunnet's post hoc test (C) and *p < 0.05; **p < 0.01; ***p < 0.001; two-tailed, unpaired t test (D).
What are the specific locales where APP and BACE-1 converge upon stimulation? As neuronal BACE-1 is largely localized to recycling endosomes in physiologic states (see above), we asked whether activity-induced APP/BACE-1 convergence increased APP/recycling-endosome colocalization as well. To test this hypothesis, we cotransfected neurons with APP:GFP and TfR:mCherry and then quantified their colocalization in dendrites after stimulation with glycine and PTX in fixed neurons (see schematic in Figure 4A ). Indeed, a larger fraction of APP was colocalized with TfR-positive vesicles in stimulated neurons (Figure 4B) . Similar experiments with APP:GFP and Rab5:mCherry (a marker for early endosomes) showed no changes in APP/Rab5 colocalization upon stimulation ( Figure 4C, left) . Similarly, BACE-1 colocalization with Rab5 was also unchanged upon activity induction as well ( Figure 4C, right) . Treatment of neurons with a b-secretase inhibitor did not influence the activity-induced changes in the APP/BACE-1 (or APP/TfR) convergence ( Figure S4A ).
The above data in fixed neurons suggest that APP and BACE-1 colocalize upon activity induction. Next, we specifically asked whether mobile APP and BACE-1 vesicles converged upon activity induction. Toward this, we cotransfected neurons with APP:GFP and BACE-1:mCh and then stimulated them with PTX. As shown in representative kymographs ( Figure 4D ) and the quantification ( Figure 4E ), there was a striking increase in colocalization of moving APP/BACE-1 (and also APP/TfR) vesicles in the PTX-treated cells, suggesting that the mobile APP/ BACE-1 particles were converging in recycling compartments upon activity induction. Finally, stimulation of neurons led to expected increases in b-CTF generation ( Figures 4F and 4G ). Taken together, these results indicate that upon neuronal activity, APP is redistributed to recycling endosomes enriched in BACE, thus facilitating b-secretase cleavage and b-CTF generation.
Activity-Induced Routing of APP into Acidic Microdomains It has been known for some time that the aspartyl-protease BACE-1 is optimally active in an acidic pH (Vassar et al., 2009) . As the intraluminal pH of recycling endosomes is also acidic (Park et al., 2006 and also see below), it is possible that routing of APP into acidic recycling endosomes is a key event preceding its cleavage. To test this idea directly, we used a pH-sensitive GFP (pHluorin) tagged to the N terminus (intraluminal end) of APP (Groemer et al., 2011) and visualized trafficking of pHl:APP in dendrites by live imaging (see schematic in Figure 5A ).
First, to test the pHluorin construct, we cotransfected neurons with pHl:APP and soluble mCherry and monitored the fluorescence before/after lowering the pH of the media to 5.5, which would be expected to globally acidify subcellular compartments (Park et al., 2006) . Note that the acidic pH dramatically quenches the pHl:APP but has no effect on the soluble mCherry fluorescence in the same neuron ( Figure 5B ), reflecting the reliability of this pH-sensitive reporter. Figure 5C shows representative kymographs of pHl:APP in dendrites before and after glycine stimulation. Note the decrease in mobile pHl:APP particles, with little change in the stationary vesicle population (quantified in Figure 5D , left). Similar experiments with APP tagged to conventional GFP showed only a slight (nonsignificant) decrease in mobile vesicles after stimulation ( Figure 5D , below). Moreover, we saw clear instances in which the fluorescence of pHl:APP was abruptly quenched upon stimulation (see example in Figure 5E ). Though such events were occasionally seen in control neurons (and we could only document them reliably in transiently paused APP vesicles), the incidence was significantly increased upon stimulation ( Figure 5E , graph and Movie S2). Thus collectively, these experiments indicate that APP is routed into acidic compartments upon stimulation. As above, treatment of neurons with a b-secretase inhibitor did not influence the activity-induced changes in pHl-APP kinetics ( Figure S4B ).
Clathrin-Mediated Endocytosis of APP Is Required for APP/BACE-1 Convergence
The above data suggest that neuronal activity leads to convergence of APP vesicles with acidic recycling endosomes containing BACE-1, leading to two possible mechanistic scenarios. One possibility is that upon activity induction, vesicles containing APP undergo endocytosis at the plasma membrane, and the endocytosed APP subsequently merges with BACE-1-positive recycling endosomes ( Figure 6A, pathway [1] ). Alternatively, APP/BACE-1 vesicles could undergo homotypic fusion (Figure 6A, pathway [2] ). To distinguish between these two possibilities, we used the dynamin inhibitor dynasore-a drug expected to block clathrin-mediated endocytosis (CME) (Macia et al., 2006) . To first characterize the effects of dynasore on CME in cultured neurons, we transfected neurons with clathrin:GFP and visualized its assembly/disassembly (''on/off'') dynamics in dendrites, known to represent coating/uncoating events in CME (Blanpied et al., 2002) . Incubation with dynasore significantly increased the lifetimes of clathrin-coated pits (CCPs) in dendrites ( Figure 6B ).
To examine the effects of endocytosis inhibition on APP/ BACE-1 colocalization, we transfected neurons with APP:GFP and BACE-1:mCherry, stimulated them with glycine in the presence or absence of dynasore, and quantified APP/BACE-1 colocalization. The main goal here was to test whether inhibition of endocytosis blocked APP/BACE-1 colocalization. As shown in the representative panels ( Figure 6C ) and the quantification below ( Figure 6D ), dynasore treatment essentially abolished the activity-dependent convergence of APP/BACE-1. However, a caveat in this experiment is that dynasore treatment would inhibit all endocytic trafficking (not just APP) and may also suppress neuronal activity. Thus, to address whether the specific inhibition of APP endocytosis would prevent its activity-induced redistribution into BACE-1-positive endosomes, we transfected neurons with APP:GFP carrying a mutation in the APP-endocytosis domain (APP-YENPTY) that is known to inhibit APP endocytosis (Perez et al., 1999) . Indeed the APP-YENPTY mutant failed to converge with BACE-1 vesicles upon stimulation (Figure 6D , image and right bar), further arguing that endocytosis of APP is specifically required for activity-dependent APP/ BACE-1 convergence. Incubation of neurons with dynasore also greatly abrogated stimulation-induced increases in b-CTFs ( Figure S4C ). Finally, incubation of neurons with dynasore did not alter any parameter of APP/BACE-1 transport in dendrites ( Figure S4D ). (B) To test the pHl:APP construct, we cotransfected neurons with pHl:APP and soluble mRFP and transferred them to an acidic environment (see Experimental Procedures). Note that while the fluorescence of the pHl:APP is dramatically quenched, there is no change in the fluorescence of soluble mRFP (all images are identically scaled, intensity ''heat maps'' shown). (C) Neurons were transfected with pHl:APP, and vesicle motility was analyzed-in the same dendrite-before and after stimulation. As shown in the representative kymographs (motile vesicles are traced below), though there was no change in the intensities of stationary APP particles, the number of mobile APP particles in dendrites were dramatically reduced after stimulation. (D) Top: quantification of motile APP particles highlights the dramatic decease upon stimulation, with little change in stationary vesicles. Bottom: similar experiments with APP tagged to conventional GFP do not show significant decreases in mobile particles upon stimulation. n z 100-200 particles analyzed for each condition in 10-15 neurons from at least two separate cultures. *p < 0.05; **p < 0.01; ***p < 0.001; two-tailed, unpaired t test. (E) Upon stimulation, instances of pHl-APP quenching were also seen as shown in selected frames from a time-lapse (also see Movie S2), further suggesting that APP was routed into an acidic compartment upon induction of neuronal activity. We analyzed 10-50 quenching events in 10-20 neurons; duration of each movie was 3 min (*p < 0.05; two-tailed, unpaired t test). A similar inhibition of APP/BACE-1 convergence was seen using an ''endocytosis-incompetent'' APP construct (YENPTY mutant, see Results), suggesting that the abrogation of APP/BACE-1 convergence was specifically related to endocytosis of APP. n z 15 neurons analyzed for each condition, from at least three separate culture sets. ***p < 0.001 compared to control by one-way ANOVA followed by Dunnet's post hoc test. (E) To visualize potential APP/clathrin interactions on the dendritic surface, we transfected neurons with clathrin:GFP and APP:mCherry, and GFP/RFP mobility was simultaneously visualized before and after adding dynasore (schematic on top). Note the typical on/off events of clathrin:GFP and bidirectional mobility of APP before adding dynasore (''before'' kymographs, left). However, upon stimulation in the presence of dynasore, the vast majority of clathrin/APP particles are stationary in dendrites (stalled vesicles marked with asterisks). Inset: a motile APP particle (red) transiently pauses at sites with stalled CCPs (green) before coming to a stop (presumably being ''trapped'' in a stalled CCP, arrowheads). (F) Note dramatic increases in stationary APP particles upon dynasore + glycine treatment. Similar experiments with BACE-1:mCherry did not show significant changes in mobile fractions. Nearly 100-120 APP and BACE-1 particles were analyzed in eight to ten neurons from two culture sets.
Neuron
Activity-Induced APP/BACE-1 Convergence To further clarify that the stimulation-induced APP endocytosis is clathrin dependent, we directly looked at APP and clathrin. We reasoned that if APP endocytosis was clathrin dependent, blocking endocytosis in the setting of stimulation would inhibit the retrieval of APP from the plasma membrane and result in the stalling (and colocalization) of APP and clathrin molecules at the surface. To test this idea, we cotransfected neurons with clathrin:GFP and APP:mCherry and simultaneously visualized both clathrin and APP fluorescence by dual-color live imaging before and after glycine stimulation (see schematic in Figure 6E ). Representative kymographs from one such experiment are shown in Figure 6E . Note that before adding dynasore, dynamics of clathrin and APP are largely distinct in dendrites. Expectedly, clathrin shows typical on/off kinetics while APP particles move bidirectionally. However, when activity is induced in the presence of dynasore, the vast majority of clathrin and APP is colocalized ( Figure 6E , right kymographs). In this setting, we also saw instances in which mobile APP particles were seemingly ''captured'' into stalled CCPs ( Figure 6E, right) . Quantification of APP movements in control and ''glycine + dynasore''-treated groups reveals a dramatic increase in stationary APP vesicles in the latter group ( Figure 6F, left) . However, there were no significant changes in BACE-1:GFP trafficking upon incubation with glycine and dynasore ( Figure 6F, right) . Collectively, these data further underline that the endocytosis of APP upon activity induction is clathrin dependent and also suggest that the mobile fraction of APP participates in this process.
Convergence of APP and BACE-1 in Alzheimer's Disease Brains Finally, we reasoned that if pathologic changes occurring in AD brains were mechanistically similar to the events suggested by our data above, one may see APP/BACE-1 convergence in AD brains as well. To test this, we took a biochemical approach. P100 ''membrane pellets'' were obtained from ten postmortem frozen human AD (and control) brain homogenates, and localization of endogenous APP and BACE-1 was evaluated in sucrose density gradients (see fractionation strategy in Figure S1G ). We found that while a spatial segregation of APP/BACE-1 was evident in age-matched control brains ( Figure 7A , top, similar to mouse brains, compare with Figure 1E ), in AD brains, significant amounts of APP was redistributed to higher-density fractions as well. Distribution of endogenous TfR in human brains ( Figure 7A , bottom) also overlapped with the BACE-1 fractions (similar to mouse brains, compare with Figure 2E ). These data are quantified in Figures 7B and 7C . Note that average APP intensity in AD brains (tenth fraction) is significantly higher than controls ( Figure 7C ). Western blots showing APP distribution in all control and AD brains, as well as distribution of various organelle markers, are shown in Figures S5 and S6A . Similar density gradients from a transgenic AD mouse model (J20) also suggested a shift in APP distribution to BACE-1-enriched higherdensity fractions ( Figure S6B ).
DISCUSSION
As both APP and BACE-1 are highly expressed in brains, and as cleavage of APP by BACE-1 is the rate-limiting step in the ''amyloid pathway,'' an outstanding question relates to basic cellular mechanisms that limit or facilitate the convergence of APP and BACE-1 in neurons. Here we explored the dynamic localization of APP and BACE-1 using cultured hippocampal neurons as a model system and also validated key predictions derived from these experiments in vivo. We found that after synthesis, APP and BACE-1 are largely sorted into distinct trafficking organelles, but neuronal activity-a known trigger of amyloidogenesis-routed APP into BACE-1-containing acidic organelles via clathrin-dependent endocytosis. As BACE-1 is optimally active in an acidic pH, our experiments suggest that neurons have evolved unique trafficking strategies that limit APP/BACE-1 proximity, and we speculate that sporadic AD pathology results from the breakdown of such well-orchestrated trafficking pathways.
Spatial Segregation of APP and BACE-1 in Physiologic States
We found that a large fraction of vesicles carrying APP and BACE-1 are spatially segregated in neurons, both in a reduced cell-culture system ( Figures 1B-1D ) and in mouse ( Figure 1E ) and human brains (Figure 7) . Though both transmembrane proteins are synthesized via the ER/Golgi as expected, BACE-1 is subsequently present in recycling endosomes. Though the exact steps by which this sorting occurs are unclear (true for neuronal cargoes in general, see Yap and Winckler, 2012) , our data showing that BACE-1 vesicles are cotransported with several markers of recycling endosomes (Figures 2A-2C ) argue that BACE-1 is largely conveyed in recycling endosomes. We posit that this simple spatial separation limits APP cleavage by BACE-1 under normal conditions, perhaps leading to the low levels of Ab physiologically detected in human brains and cerebrospinal fluid.
A Pathway for Activity-Dependent Convergence of APP and BACE-1 Substantial evidence indicates that neuronal activity triggers amyloidogenesis (reviewed in Haass et al., 2012) . We found that various paradigms inducing activity in cultured neurons also led to increased colocalization of APP/BACE-1, as well as a routing of APP into recycling endosomes containing BACE-1 (Figures 3 and 4) , along with increased b-cleavage of APP (Figure 4F) . Early studies in cell lines suggested that APP/BACE-1 convergence occurs at or perhaps near the plasma membrane (Kinoshita et al., 2003; von Arnim et al., 2008) , but more recent data (also mostly in nonneuronal cells or neuronal cell lines) suggest that these two proteins converge within early endosomes (Rajendran et al., 2006; Sannerud et al., 2011) . Other studies show that APP and Rab5 may colocalize in presynaptic terminals (Ikin et al., 1996; Sabo et al., 2003) . However, in our experiments, mobile BACE-1 vesicles in dendrites show scant colocalization with Rab-5, a marker of early endosomes ( Figure 2B, bottom) . Moreover, although APP is routed to TfR-positive recycling endosomes upon glycine or PTX stimulation ( Figure 4B) , there is no increase in APP colocalization with Rab-5 upon activity induction ( Figure 4C ). Though these data suggest that the activity-induced convergence of APP and BACE-1 occur in neuronal recycling endosomes, we cannot exclude the possibility of such convergence in early endosomes as well. For example, given the known dynamics of endosomes, a transitory convergence of APP/BACE-1 in early endosomes (before their appearance in recycling compartments) is conceivable. Nevertheless, the available data supports our model ( Figure 6A, pathway [1] ) and provides a potential starting point for further work that may more precisely pinpoint the temporal kinetics of such convergence.
What are the specific cell biological mechanisms that lead to activity-dependent APP/BACE-1 convergence? A recent study suggested that activity-dependent APP processing may occur in cholesterol-rich microdomains (Sakurai et al., 2008) . Worley and colleagues also recently showed that activity-induced Arc induction led to increased g-secretase processing of APP in dendrites (Wu et al., 2011) , but early mechanisms leading to the convergence of APP/BACE-1-initiating the rate-limiting step of b-cleavage-remained unclear. We found that endocytosis of APP is essential for the activity-dependent convergence of APP/BACE-1 in neurons (Figure 6 ). Specifically, experimental Figure S6 ). P100 ''vesicle-pellet'' fractions were layered and separated on sucrose density gradients and immunoblotted with antibodies to APP and BACE-1. Similar to mouse brain homogenates ( Figure 1E ), endogenous APP and BACE-1 were largely localized to separate density fractions. However, in AD brains, more APP was seen in the highest-density fractions that also contain BACE-1 (fractions 10, hatched red box), suggesting APP/BACE-1 convergence. (B) Densitometry analysis of the APP/BACE-1 fractions. For a given protein, the band intensity in each lane was normalized to the maximum band intensity of that protein over the ten lanes. Note the relative increases in APP band intensities in higher-density fractions from AD brains (red dashed box). (C) Average APP blot intensities plotted from the data shown in (B). Note the shift in APP distribution to higher-density fractions in AD brains. (*p < 0.05; two-tailed, unpaired t test).
paradigms blocking clathrin-mediated endocytosis (or APP endocytosis) also abrogated APP/BACE-1 convergence ( Figures  6C and 6D ), and such conditions led to expected stalling and clustering of APP and clathrin ( Figure 6E ), suggesting that a recycling-dependent pathway (as opposed to homotypic fusion) is responsible for this convergence.
What is the relevance of our findings to human disease? Studies show that amyloid plaque deposition is most conspicuous in the ''default mode network''-a circuit that is metabolically active during unidirected mentation (Buckner et al., 2009 )-leading to the hypothesis that activity-dependent amyloidogenesis may play a role in AD (Bero et al., 2011) . Though our experiments do not address this directly, our finding that APP/BACE-1 convergence is exaggerated in stimulated neurons as well as AD brains is consistent with this idea. However, other studies implicate defective Ab clearance (and not increased Ab production) as the primary pathologic event in AD (Mawuenyega et al., 2010) , and further work is needed to clarify these issues. In summary, our studies uncover fundamental trafficking strategies by which neurons largely restrict APP (substrate) and BACE-1 (enzyme) in distinct organelles-thus limiting Ab biogenesis in physiologic states (Figures 1 and 2) ; define a trafficking pathway by which APP and BACE-1 converge upon induction of neuronal activity (Figures 3, 4 , 5, and 6); and, finally, our data from human brains (Figure 7 ) suggest potential relevance of these mechanisms in human disease.
EXPERIMENTAL PROCEDURES
DNA Constructs, Antibodies, and Reagents Several constructs were obtained from other laboratories, as mentioned in the Acknowledgments. The CFP/YFP tags in the BACE-1:CFP/APP:YFP constructs were replaced by GFP or mCherry, cloned in-frame, and confirmed by sequencing (see Figure S1 ). The promoter in the NPYss construct (Banker laboratory) was swapped with CMV. The clathrin:GFP and Rab-5:mCherry constructs were obtained from Addgene. Antibodies used for biochemistry were the following: APP (1565-1; Epitomics), BACE1 (MAB931; R&D), TfR (clone H68.4; Invitrogen), Tubulin (clone DM1A, Sigma), anti-pan cadherin (ab22744, Abcam), KDEL (Ab12223, Abcam), Rab11 (71-5300, Invitrogen), GM130 (610822, BD Transduction), and Rab5 (108011, Synaptic Systems). D-AP5, dynasore, picrotoxin, and memantine were from Sigma and Alexa 488 Transferrin was from Molecular Probes. Beta-secretase Inhibitor II (Calbiochem) was prepared in DMSO and neurons were treated with final 0.5 mM inhibitors for 24 hr.
Hippocampal Cultures and Transfection
Primary hippocampal neurons were obtained from postnatal (P0-P1) CD-1 mice and cells were transfected using Lipofectamine-2000 (Invitrogen) as described previously in Roy et al. (2012) . Briefly, dissociated neurons were plated at a density of 50,000 cells/cm 2 in poly-D-lysine-coated (1.0 mg/ml) glass-bottom culture dishes (MatTek) and maintained in Neurobasal/B27 media (Invitrogen) supplemented with 0.5 mM glutamine. All experiments examining colocalization in fixed neurons, as well as all experiments with clathrin:GFP, were performed in DIV15-DIV18 neurons. All transport assays were performed in DIV6-DIV8 neurons, as thicker dendrites in older neurons precluded reliable imaging. All animal studies were carried out in accordance with University of California guidelines.
Microscopy, Live Cell Imaging, and Transport Data Analysis All assays were performed 4-6 hr posttransfection, on low expressers, except when noted in the figures. For each group, we analyzed 100-200 vesicles from 10-15 dendrites, and each experiment was repeated in at least two to three separate sets of cultures. Just before imaging, neurons were transferred to Hibernate-E-based ''live imaging'' at 35 C-37 C . Distal region of the primary dendrite or the secondary dendrites (first-order branch) were selected for imaging. All time-lapse movies were acquired using an Olympus IX81 inverted epifluorescence microscope with a Z-controller (IX81, Olympus), a motorized X-Y stage controller (Prior Scientific), and a fast electronic shutter (SmartShutter). Images were acquired using an ultrafast light source (Exfo exacte) and high-performance chargecoupled device cameras (Coolsnap HQ2, Photometrics). Image acquisitions were performed using MetaMorph software (Molecular Device). Simultaneous imaging of two spectrally distinct fluorophores was performed using a ''dual cam'' imaging system (Photometrics), a device that splits the emission wavelengths into separate (red/green) channels. Fluorescence intensity was attenuated to 50% to minimize photobleaching. Imaging parameters were set at 1 frame/s, total 200 frames and 200-400 ms exposure with 2 3 2 camera binning, totaling to 2,000 s of total imaging time for each group, suitable to capture the infrequent transport events in dendrites. For transport analysis, kymographs were generated in MetaMorph, and segmental tracks were traced on the kymographs using a line tool and individual lines were saved as ''.rgn'' files, and the resultant velocity data (distance/time) were obtained for each track as described in Tang et al. (2012) . Frequencies of particle movements were calculated by dividing the number of individual particles moving in a given direction by the total number of analyzed particles in the kymograph. For cotransport assays, dual cam videos were separated using ''split view'' menu and kymographs were generated for each channel (red/green). Segmental tracks were traced as mentioned above and individual lines were compared manually for each pair of kymographs for one particular video. Vesicles (red/ green) were considered cotransported/colocalized if the traced lines merged when kymographs were overlaid.
Colocalization Analysis
Neurons were cotransfected with desired constructs, and cells were fixed after 6-12 hr using 4% paraformaldehyde/4% sucrose. Z stack images were captured using a 1003 objective with these constant imaging parameters: 0.2 mm z step, 400-800 ms exposure, 1 3 1 binning, and deconvolved using the ''Classic Maximum Likelihood Estimation'' algorithm (Huygens, Scientific Volume Imaging B.V.). Deconvolved z stacks were then subjected to a maximum intensity projection, resulting in two-dimensional (2D) images for processing. Subsequent processing for all images was as performed in three steps as described below: (1) registration between images was optimized using a 2D cross-correlation algorithm, (2) images were thresholded, and (3) colocalization was calculated as the fraction of area overlapping between the above-threshold structures in each image. Image alignment and colocalization analysis was performed using custom algorithms written in MATLAB (MathWorks). For temperature block experiments, cells were first imaged at 37 C, followed by 2 hr incubation at 20 C, and reimaged.
Activity Induction, Drug Treatments, and Alexa TfR Labeling Glycine stimulation was performed in DIV15-DIV17 neurons, essentially as described by Park et al. (2006) . Briefly, neurons were incubated at 37 C for 5 min in E4 solution containing 124 mM NaCl, 2 mM CaCl2, 3 mM KCl, 10 mM HEPES, and 10 mM glucose (pH 7.4). Activity was induced with E4 supplemented with 20 mM bicuculine and 200 mM glycine for 5 min, and finally in E4 with 20 mM bicuculine for 15 min before fixation and imaging. For picrotoxin (PTX) stimulation, cells were incubated in 100 mM PTX at 37 C for the desired time and fixed. In experiments with NMDA inhibitors, neurons were either treated with 50 mM D-APV for 2 hr or 10 mM memantine for 4 hr and then activation as mentioned in the text. Dynasore was used at 40 mM for 30 min at 37 C prior to activity induction and imaging. To test the pHl:APP (see Figure 5B ), we replaced neurons incubated in HEPES with MES to obtain a pH of 5.5, keeping other components in the remaining imaging buffer unchanged (124 mM NaCl, 2 mM CaCl2, 3 mM KCl, 10 mM MES, and 10 mM glucose [pH 5.5]), as described by Park et al. (2006) . To label actively recycling endosomes, we loaded neurons with 50 mg/ml Alexa 488 transferrin (Invitrogen) diluted in imaging medium for 1 hr at 37 C, rinsed extensively, and imaged immediately thereafter.
Neuron
Activity-Induced APP/BACE-1 Convergence Biochemical Analysis of Mouse and AD Brain Tissue Sequential isolation and density gradient centrifugation were performed to fractionate vesicular fractions as described previously by Scott et al. (2011) . Briefly, brains from 4-to 6-week-old CD-1 mice, or frontal lobe dissected from postmortem frozen human brains (three AD Braak V/VI and two controls, obtained from the AD Research Center brain bank at UCSD), were homogenized in buffer containing 20 mM HEPES, 40 mM KCl, 5 mM EDTA, 5 mM EGTA, and protease inhibitor (pH 7.2). Tissue lysate was centrifuged at 1,000 3 g for 15 min to isolate postnuclear supernatant (S1). S1 was centrifuged at 10,200 3 g for 20 min to obtain synaptosome-depleted fraction (S2). Finally, S2 fraction was centrifuged at 100,000 3 g for 1 hr at 4 to isolate soluble (S100) and vesicular (P100) fraction. For floatation assays, P100 fractions were adjusted to 45% sucrose and bottom loaded on a 5%-45% sucrose gradient and centrifuged at 160,000 3 g for 16 hr at 4 C in an SW55-Ti rotor in an Optima L-100 ultracentrifuge (Beckman-Coulter). Ten fractions of 0.5 ml each were collected from top of the gradient column and equal volumes were used for SDS-PAGE and western blot analysis. Blots were developed by using Pierce Fast Western Blot kit ECL Substrate, visualized by using Versa Doc Imaging system (Bio-Rad), and quantified by densitometry. For ex vivo biochemical assays to detect APP-CTFs, DIV16-DIV18 neurons (50,000 cells/well) were treated with 100 mM PTX in presence of 100 nM gamma-secretase inhibitor BMS-299897 (Anderson et al., 2005) . Cells were lysed in Laemmli buffer and resolved on 16% Tricine gel.
Statistical Analysis
Routine statistical analyses were performed using Prism software (Graphpad) using the Student's t test for comparing two groups and one-way ANOVA for multiple groups. A p value of <0.05 was considered significant. For curve fitting ( Figure 1C ), the Bayesian Information Criterion was used to select a secondorder Gaussian model for fitting of the velocity data.
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